AGP Executive Report
Last update: 10 hours agoAlzheimer’s Research: A new mouse study in eNeuro suggests inhaled CBD may help calm brain immune inflammation tied to Alzheimer’s progression. Arthritis Pain: A Clinical Therapeutics study reports CBD/CBDa and THC capsule combinations eased chronic pain across fibromyalgia, rheumatoid arthritis, and osteoarthritis without major cognitive impacts. Medical Access (Kentucky): Speakeasy Dispensary says it will open a new Bowling Green location June 5 to expand patient access to Kentucky’s medical cannabis program. Regulatory Shock (Texas Delta-8): Texas Delta-8 gummies and drinks lose their broad availability as a court stay ends, with state health officials treating them as Schedule I. Public Health Alerts (Missouri): Missouri regulators issued a recall for certain THC vape cartridges after processing-related testing gaps were found. Policy & Industry: Lawmakers push the IRS for “prompt” tax guidance for cannabis businesses after rescheduling, while multiple AGs sue to block federal marijuana reclassification. Community Impact (B.C.): Victoria’s Cannabis Buyers Club faces potential shopfront seizure, with supporters arguing it keeps patients alive through low-cost medicine.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
